Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model
Open Access
- 21 May 2018
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 1-16
Abstract
Prostate cancer (PCa) is a fatal malignant tumor among males in the world and the metastasis is a leading cause for PCa death. Biomarkers are therefore urgently needed to detect PCa metastatic signature at the early time. MicroRNAs are small non-coding RNAs with the potential to be biomarkers for disease prediction. In addition, computer-aided biomarker discovery is now becoming an attractive paradigm for precision diagnosis and prognosis of complex diseases. In this study, we identified key microRNAs as biomarkers for predicting PCa metastasis based on network vulnerability analysis. We first extracted microRNAs and mRNAs that were differentially expressed between primary PCa and metastatic PCa (MPCa) samples. Then we constructed the MPCa-specific microRNA-mRNA network and screened microRNA biomarkers by a novel bioinformatics model. The model emphasized the characterization of systems stability changes and the network vulnerability with three measurements, i.e. the structurally single-line regulation, the functional importance of microRNA targets and the percentage of transcription factor genes in microRNA unique targets. With this model, we identified five microRNAs as putative biomarkers for PCa metastasis. Among them, miR-101-3p and miR-145-5p have been previously reported as biomarkers for PCa metastasis and the remaining three, i.e. miR-204-5p, miR-198 and miR-152, were screened as novel biomarkers for PCa metastasis. The results were further confirmed by the assessment of their predictive power and biological function analysis. Five microRNAs were identified as candidate biomarkers for predicting PCa metastasis based on our network vulnerability analysis model. The prediction performance, literature exploration and functional enrichment analysis convinced our findings. This novel bioinformatics model could be applied to biomarker discovery for other complex diseases.Keywords
Funding Information
- National Natural Science Foundation of China (31670851, 31470821, 91530320, 31770903)
- National Key Research and Development Program of China (2016YFC1306605)
This publication has 77 references indexed in Scilit:
- Interactions Between Genetics, Lifestyle, and Environmental Factors for Healthcare2017
- Naringenin‐Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling PathwaysJournal of Cellular Biochemistry, 2017
- MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cellsJournal of Cancer Research and Clinical Oncology, 2016
- Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfacesClinical & Experimental Metastasis, 2015
- miR‐204 is dysregulated in metastatic prostate cancer in vitroMolecular Carcinogenesis, 2015
- Expression of TRAP1 Predicts Poor Survival of Malignant Glioma PatientsJournal of Molecular Neuroscience, 2014
- Predictive value of circulating miR-328 and miR-134 for acute myocardial infarctionMolecular and Cellular Biochemistry, 2014
- EMP1 regulates caspase-9 and VEGFC expression and suppresses prostate cancer cell proliferation and invasionTumor Biology, 2013
- Endoglin suppresses human prostate cancer metastasisClinical & Experimental Metastasis, 2010
- RNASEL germline variants are associated with pancreatic cancerInternational Journal of Cancer, 2005